Track 6: Cancer Drug Resistance has been postponed

We encourage you to review other available conference programming at Biomarkers & Diagnostics World Congress 2013, our leading annual meeting dedicated to biomarkers and diagnostics research and implementation, which is expecting 25% growth over last year.